Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...
Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...
For more than two decades, researchers at the University of Basel, Switzerland, have been investigating a severe form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback